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Objectives The aim of this study was to determine the best intravascular ultrasound (IVUS) criteria
for predicting physiological signiﬁcance of left main (LM) stenosis with fractional ﬂow reserve (FFR)
as the standard.
Background For identifying signiﬁcant LM disease, optimal cutoff of minimal lumen area (MLA) and
its accuracy remain debatable.
Methods We identiﬁed 55 patients (31 stable and 24 unstable angina) with an isolated LM lesion of
30% to 80% angiographic diameter stenosis who underwent IVUS and invasive physiological assess-
ment before intervention.
Results The FFR at maximum hyperemia signiﬁcantly correlated with IVUS-measured MLA within
the LM (r  0.623, p  0.001), plaque burden (r  0.548, p  0.001), angiographic diameter ste-
nosis (r  0.449, p  0.002), and angiographic length of the lesion (r  0.292, p  0.046). The
FFR was signiﬁcantly lower in 18 lesions with plaque rupture than 37 lesions without plaque rupture
(0.76  0.09 vs. 0.82  0.09, p  0.018). The independent determinants of FFR as a continuous vari-
able were MLA (beta  0.598, p  0.001) and plaque rupture (beta  0.255, p  0.038). Further-
more, the MLA within the LM was the only independent determinant for FFR 0.80 (adjusted odds
ratio: 0.312, p  0.001) and for FFR 0.75 (adjusted odds ratio: 0.196, p  0.001). The IVUS MLA
value within the LM that best predicted FFR 0.80 was 4.8 mm2 (89% sensitivity, 83% speciﬁcity).
In addition, the cutoff value of plaque burden to predict FFR 0.80 was 72% (73% sensitivity, 79%
speciﬁcity). The best cutoff values of the MLA and plaque burden for predicting FFR 0.75 were
4.1 mm2 (95% sensitivity, 83% speciﬁcity) and 76% (79% sensitivity, 80% speciﬁcity), respectively.
Conclusions In isolated LM disease, an IVUS-derived MLA 4.8 mm2 is a useful criterion for predict-
ing FFR 0.80. (J Am Coll Cardiol Intv 2011;4:1168–74) © 2011 by the American College of
Cardiology Foundation
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1169Recent studies have suggested that fractional flow reserve
(FFR)-guided percutaneous coronary intervention (PCI) is
associated with reduced major adverse cardiac events in
patients with multivessel coronary artery disease (1–3).
Furthermore, FFR 0.75 to 0.80 is a strong predictor of
excellent survival and low event rates in patients with
intermediate left main (LM) disease, making it useful to
identify patients in whom deferral of revascularization is
associated with favorable clinical outcomes (4–9).
Because angiographic assessment of LM stenosis severity
is not accurate (10,11), there have been attempts to find
intravascular ultrasound (IVUS) measurements that corre-
spond to the functional significance and clinical outcomes
and to integrate morphological, physiological, and long-term
follow-up data. The suggested minimal lumen area (MLA)
cutpoint has varied from 5.9 to 9.6 mm2 for identifying
significant LM disease; therefore, the optimal cutoff value and
its accuracy remain debatable (7,12,13). The aim of this study
was to determine the best IVUS criteria for predicting physi-
ological significance of intermediate isolated LM lesions with
FFR as the standard.
Methods
Study population. Between January 2010 and April 2011,
oronary angiography identified de novo LM disease in 145
atients. After excluding patients with regional wall motion
bnormality, significant distal lesions (angiographic diame-
er stenosis [DS] 50% within the left anterior descending
rtery [LAD] or left circumflex artery, either sequential or
andem involvement), myocardial infarction, or angio-
raphic thrombi-containing lesions and cases in which the
VUS-imaging catheter failed to cross the lesion due to
ight stenosis or tortuosity, we identified 55 consecutive
atients (31 stable angina and 24 unstable angina) with an
solated LM lesion of 30% to 80% angiographic DS on
isual estimation. These patients underwent IVUS and
nvasive physiological assessment before intervention.
reatment strategies were at the discretion of the operator.
his study was approved by the institutional review board,
nd all patients provided written informed consent.
Angiographic analysis. Qualitative and angiographic analy-
is was done by standard techniques with automated edge-
etection algorithms (CASS-5, Pie-Medical, Maastricht,
he Netherlands) in the angiographic analysis center of the
ardioVascular Research Foundation, Seoul, Korea. Mini-
al lumen diameter, DS, and lesion length were measured
n the least foreshortened view. Lesion location was based
n the site of minimal lumen diameter within the LM.
FFR measurement. “Equalization” was performed with the
uidewire sensor positioned at the guiding catheter tip.
hen, the 0.014-inch pressure guidewire (Radi, St. Jude
edical, Uppsala, Sweden) was advanced into the coronaryrtery and positioned 3 cm distal to the LM lesion intohe LAD or left circumflex artery, depending on which was
east diseased distally. The FFR was measured at maximal
yperemia induced by intravenous adenosine infusion, ad-
inistered at 140 to 180 g/kg/min through a central vein.
Hyperemic pressure pullback recordings were performed as
described previously (8,14,15). In patients with an ostial
LM stenosis, care was taken to pull the guiding catheter out
of the LM during FFR assessment.
IVUS imaging and analysis. After FFR assessment, LAD-
ullback IVUS imaging was performed after intracoronary
dministration of 0.2 mg nitroglycerin with motorized
ransducer pullback (0.5 mm/s) and a commercial scanner
Boston Scientific/SCIMED, Minneapolis, Minnesota)
onsisting of a rotating 40-MHz transducer within a 3.2-F
maging sheath. With computerized planimetry (Echo Plaque 3.0,
ndec Systems, MountainView,
alifornia), off-line quantitative
VUS analysis was performed as
reviously described (16) in a core
aboratory at the Asan Medical
enter. At the site of the smallest
umen within the LM segment
bove the carina, MLA and exter-
al elastic membrane (EEM) area
ere measured. Plaque burden
PB) at the MLA site was calcu-
ated as: (EEM area  lumen
rea)/EEM area  100(%).
Statistical analysis. All statistical
analyses were performed with
SAS (release 9.1, SAS Institute,
Inc., Cary, North Carolina) or
SPSS (version 10.0, SPSS, Inc.,
Chicago, Illinois). All values are
expressed as mean  1 SD (con-
tinuous variables) or as count and
percentage (categorical variables).
Continuous variables were com-
pared by use of the nonparametric
Mann-Whitney test or Kruskal-Wallis test; categorical vari-
ables were compared with the chi-square statistic or Fisher
exact test.
Stepwise multiple linear regression analysis was per-
formed to assess the independent predictors for FFR as a
continuous variable, including the variables, such as lesions
location, MLA, PB, angiographic DS, lesion length, and
presence of plaque rupture. To ascertain independent pre-
dictors of FFR as binary variable (FFR 0.80 and FFR
0.75), multivariable logistic regression analysis was also
performed.
To determine FFR 0.80 and FFR 0.75, receiver-
operator characteristic (ROC) curves were analyzed to assess
the best cutoff values of IVUS parameters that minimize the
Abbreviations
and Acronyms
AUC  area under the curve
CI  confidence interval
DS  diameter stenosis
EEM  external elastic
membrane




LAD  left anterior
descending artery
LM  left main coronary
artery
MLA  minimal lumen area
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1170MedCalc (MedCalc Software, Mariakerke, Belgium). The
sensitivity, specificity, positive predictive value, and negative
predictive value with 95% confidence intervals (CIs) were
obtained. A p value 0.05 was considered statistically
significant.
Results
Clinical and angiographic characteristics. The clinical char-
acteristics and angiographic findings in 55 patients with 55
coronary lesions are summarized in Tables 1 and 2. The






(n  29) p Value
Age, yrs 60 12 58 11 61 12 0.287
Male 41 (75%) 21 (81%) 20 (69%) 0.245
Ejection fraction, % 62 6 62 7 60 5 0.329
Diabetes 16 (29%) 8 (31%) 8 (28%) 0.514
Hypertension 27 (49%) 14 (54%) 13 (45%) 0.346
Smoking 31 (56%) 17 (65%) 14 (48%) 0.157
Hyperlipidemia 40 (73%) 20 (77%) 20 (69%) 0.361
Previous PCI 10 (18%) 4 (15%) 6 (21%) 0.391
Renal failure 2 (4%) 1 (4%) 1 (4%) 0.439
Clinical manifestation
Stable angina 31 (56%) 14 (54%) 17 (58%) 0.671
Unstable angina 24 (44%) 12 (46%) 12 (41%)
Values aremean SD or n (%). Fractional flow reserve (FFR)0.80 vs. FFR0.80.
LM left main coronary artery; PCI percutaneous coronary intervention.




Angiographic ulceration 5 (11%)
Proximal reference diameter, mm 3.9 0.6
Distal reference diameter, mm 3.5 0.5
Interpolated diameter, mm 3.7 0.5
Minimal lumen diameter, mm 2.0 0.5
Diameter stenosis, % 47.7 11.6
Lesion length, mm 10.8 5.4
IVUS ﬁndings
At MLA site within LM
MLA, mm2 4.9 2.4
EEM area, mm2 17.8 5.5
Plaque burden, % 69.3 15.4
At the LAD ostium
MLA, mm2 5.9 2.3
EEM area, mm2 13.5 3.8
Plaque burden, % 57.0 15.4
Values are n (%) or mean SD. *Fractional flow reserve (FFR)0.80 v
EEM  external elastic membrane; IVUS  intravascular ultrasounartery; MLAminimal lumen area.lesion location was LM ostium in 27 (49%) lesions and LM
shaft in 10 (18%) lesions. In the remaining 18 (33%) distal
LM lesions, Medina classification was 1,1,1 in 3 lesions;
1,1,0 in 4 lesions; 1,0,0 in 9 lesions; and 1,0,1 in 2 lesions.
Quantitative coronary angiographic DS was 47.7  11.6%
(range 30% to 78%). Overall, 26 (47%) lesions had FFR
0.80, and 19 (35%) lesions had FFR 0.75 at maximum
hyperemia. There was a trend for a worse angiographic DS
in the lesions with FFR 0.80 versus FFR 0.80 (50.5 
12.6% vs. 44.8  10.3%, p  0.070); however, this did not
reach statistical significance. There was no significant dif-
ference in FFR between stable angina versus unstable
angina presentation (0.80  0.08 vs. 0.81  0.11, p 
0.797) or patients with diabetes versus without diabetes
(0.81  0.10 vs. 0.79  0.08, p  0.377).
IVUS ﬁndings. Table 2 summarizes the IVUS findings.
Plaque rupture was seen in 18 (33%) lesions, and the most
frequent rupture sites were LM ostium and shaft locations
(13 of 18 [77%]). The MLA and FFR were 5.6  1.9 mm2
and 0.83  0.10 in ostial LM lesions; 3.5  1.5 mm2 and
0.79 0.09 in shaft lesions; and 4.1 1.8 mm2 and 0.77 0.07
n distal LM lesions (p  0.008 for MLA, and p  0.02 for
FR among the 3 groups).
Determinants for FFR. The FFR at maximum hyperemia
significantly correlated with IVUS-measured MLA within
the LM (r 0.623, p 0.001), IVUS-measured PB within
the LM (r  0.548, p  0.001), angiographic DS (r 
0.449, p  0.002), and angiographic length of the lesion
(r  0.292, p  0.046). Although there was no difference




(n  29) p Value*
3 (13%) 2 (8%) 0.601
3.8 0.6 4.1 0.6 0.174
3.4 0.4 3.7 0.5 0.151
3.6 0.5 3.8 0.4 0.063
1.8 0.5 2.1 0.6 0.004
50.5 12.6 44.8 10.3 0.070
13.0 5.2 8.8 4.1 0.001
3.4 1.2 6.3 2.3 0.001
16.8 3.6 18.7 6.7 0.202
77.5 10.8 61.9 15.6 0.001
5.6 2.0 6.2 2.6 0.396
12.8 3.0 14.1 4.3 0.230
56.9 13.0 57.1 17.8 0.566
0.80.
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1171in the MLA between lesions with and without plaque
rupture, FFR was significantly lower in 18 lesions with
plaque rupture than 37 lesions without plaque rupture (0.76 
.09 vs. 0.82  0.09, p  0.018).
Multivariable linear and logistic regression analysis in-
cluded MLA, PB, angiographic DS, lesion location, lesion
length, and presence of plaque rupture. The independent
determinants of FFR as a continuous variable were MLA
(beta  0.598, 95% CI: 0.017 to 0.040, p  0.001) and
plaque rupture (beta  0.255, 95% CI: 0.088 to
0.005, p  0.038). Table 3 shows the results of univari-
able analysis to predict an abnormal FFR as a dichotomous
variable. The MLA within the LM was the only indepen-
dent determinant for FFR 0.80 (adjusted odds ratio:
0.312, 95% CI: 0.164 to 0.593, p  0.001) and for FFR
0.75 (adjusted odds ratio: 0.196, 95% CI: 0.076 to 0.501,
p  0.001).
Cutoff values of predictors for abnormal FFR. The IVUS
LA value within the LM (minimizing the distance
etween the curve and the upper corner of the graph) that
est predicted FFR 0.80 was 4.8 mm2 (89% sensitivity,
3% specificity, area under the curve [AUC]: 0.90, 95% CI:
.788 to 0.964, p  0.001) (Fig. 1). The overall diagnostic
ccuracy was 86% (Fig. 2) with a CI of 2.9 to 5.2 mm2. In
3 (82%) of 28 lesions with an MLA 4.8 mm2, FFR was
0.80. Among 27 lesions with an MLA 4.8 mm2, 3
(11%) had FFR 0.80, and only 1 (4%) had FFR 0.75
(Fig. 2). In addition, the cutoff value of PB to predict FFR
0.80 was 72% (sensitivity 73%, specificity 79%, AUC:
.79, 95% CI: 0.664 to 0.891, p  0.001).
Furthermore, the IVUS-measured MLA that best pre-
icted FFR 0.75, was 4.1 mm2 (95% sensitivity, 83%
specificity, and AUC: 0.92, 95% CI: 0.810 to 0.976, p 
0.001). The overall diagnostic accuracy was 87% (Fig. 2)
with a CI of 3.2 to 4.1 mm2. Among 31 lesions with an
Table 3. Univariable Analysis to Predict Abnormal FFR
Prediction of FFR <0.80
Variables C-OR 95% CI
MLA within LM 0.312 0.164–0.593
Plaque burden 1.095 1.031–1.164
Lesion length 1.192 1.038–1.368
Rupture 3.273 0.953–11.243
Angiographic DS 1.049 0.993–1.108
Lesion location 2.081 1.070–4.046
Male 0.511 0.127–2.057
Age 0.965 0.917–1.016




Stable presentation 0.476 0.078–2.894CI confidence interval; C-OR corrected odds ratio; DS diameter stenosis; other abbreviations as in TMLA 4.1 mm2, all but 1 (97%) lesion had FFR 0.75,
and that lesion had a plaque rupture. In addition, the cutoff
value of PB to predict FFR 0.75 was 76% (sensitivity
79%, specificity 80%, AUC: 0.84, 95% CI: 0.718 to 0.925,
p  0.001).
When subgroup analysis included only 37 lesions without
plaque rupture, the cutoff value of the MLA for predicting
FFR 0.75 was 4.8 mm2 with a sensitivity of 93% and a
specificity of 86% (AUC: 0.935, p 0.001). Conversely, in 18
lesions with plaque rupture, the MLA 4.8 mm2 predicted
FFR 0.80 with a sensitivity of 83% and a specificity of 67%.
n addition, the diagnostic accuracy was only 77%.
In the 15 lesions with IVUS MLA 6.0 mm2, all but 1
(93%) showed FFR 0.80, and FFR 0.75 was completely
xcluded. However, among 40 lesions with an IVUS MLA
6.0 mm2, 15 (38%) had FFR0.80, and 21 (58%) had FFR
0.75.
An angiographic DS 48% was the best cutoff on ROC
urve, but a poor predictor of FFR 0.80 (sensitivity 51%,
pecificity 75%, AUC: 0.654, 95% CI: 0.501 to 0.787, p 
.070). An FFR0.80 was demonstrated in 11 (38%) of 29
esions with an angiographic DS 48%, and FFR 0.80
was seen in 6 (33%) of 18 lesions with DS 48%.
Treatment. Overall, 29 patients underwent PCI, and 1
atient underwent coronary artery bypass surgery at the
iscretion of the operator. Revascularization was performed
n 18 (95%) of 19 lesions with FFR 0.75, 5 (71%) of 7
esions with FFR 0.75 to 0.80, and 7 (29%) of 24 lesions
ith FFR 0.80.
iscussion
The major findings of this study of intermediate LM lesions
are the following: 1) IVUS-measured MLA within the LM
was the independent determinant for both FFR 0.80 and
Prediction of FFR <0.75
Value C-OR 95% CI p Value
0.001 0.196 0.076–0.501 0.001
0.003 1.142 0.050–1.241 0.002
0.013 1.102 0.981–1.237 0.102
0.060 3.143 0.895–11.034 0.074
0.088 1.078 1.013–1.147 0.020
0.031 1.851 0.934–3.670 0.078
0.345 0.663 0.149–2.947 0.590
0.172 0.994 0.944–1.047 0.826
0.924 0.700 0.180–2.725 0.607
0.654 2.671 0.749–9.531 0.130
0.104 2.062 0.579–7.347 0.264
0.814 0.765 0.203–2.889 0.693
0.420 0.347 0.037–3.253 0.354p
able 2.
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1172FFR 0.75 at maximal hyperemia; 2) the best cutoff value
to predict FFR0.80 and FFR0.75 were an IVUS MLA
of 4.8 mm2 and 4.1 mm2, respectively; and 3) plaque rupture
in the LM was frequent and independently affected the FFR
and the FFR versus IVUS correlation.
Previous studies have demonstrated that FFR 0.75 to
0.80 was a strong predictor of favorable clinical outcomes in
patients with intermediate LM disease (4–8). On the basis
of FFR 0.75 and FFR 0.75, Jasti et al. (7) reported that
the 38-month survivals were 100% versus 100% and event-
free survival estimates were 100% versus 90%, respectively
(all, p  0.05). When treatment strategy of equivocal LM
stenosis was determined by FFR 0.80 (bypass surgery)
versus 0.80 (medical therapy), 5-year survival estimates
were similar between surgical and nonsurgical groups
(85.4% vs. 89.8%, p  0.48), as were the 5-year event-free
survival estimates (74.2% vs. 82.8%, p  0.50) (9). Thus,
FFR measurement is appropriate to identify patients with
Figure 1. Cutoff Values and Diagnostic Accuracies
(A) Cutoff values and diagnostic accuracies of intravascular ultrasound-derived
off values and diagnostic accuracies of plaque burden (PB) for FFR 0.80. (C)
values and diagnostic accuracies of plaque burden for FFR 0.75. AUC  area
PPV  positive predictive value.intermediate LM stenosis in whom deferral of revascular-ization is associated with excellent survival and low event
rates.
Despite the statistically significant correlation between
angiographic DS and FFR as continuous variables in the
current study, there was a large scatter; and there was no
angiographic DS that accurately predicted an abnormal
FFR, consistent with previous results (10,11). In the current
study more than one-third of the lesions were misclassified
with angiographic assessment alone.
Studies have differed on the cutoff value of the IVUS-
derived MLA that identified a significant LM stenosis
(7,12,13). With the mean minus 2 SDs of MLA measure-
ments in patients with a normal LM, Fassa et al. (12)
reported that an MLA7.5 mm2 seemed to be safe to defer
revascularization. Furthermore, on the basis of the long-
term outcomes, the best cutoff of the MLA for performing
or deferring revascularization was 9.6 mm2 by ROC (12).
issen et al. (13) proposed an absolute area 9 mm2 as a
al lumen area (MLA) predicting fractional ﬂow reserve (FFR) 0.80. (B) Cut-
values and diagnostic accuracies of MLA predicting FFR 0.75. (D) Cutoff
r the curve; CI  conﬁdence interval; NPV  negative predictive value;minim
Cutoff
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1173as the “gold standard,” Jasti et al. (7) reported that an MLA
of 5.9 mm2 had the highest sensitivity and specificity (93%
nd 95%, respectively) for determining a significant LM
tenosis.
In the current study, the cutoff value that best predicted
n abnormal FFR was lower than previously suggested.
mong 28 lesions with an IVUS MLA 4.8 mm2, 23
(82%) had FFR 0.80, and 18 (64%) had FFR 0.75.
Conversely, among 40 lesions with an IVUS MLA 6.0
mm2, only 19 (48%) had FFR 0.75, and 25 (63%) had
FFR 0.80. Thus, an MLA 6.0 mm2 was less specific for
predicting an abnormal FFR (a specificity of 48% for FFR
0.80 and a specificity of 42% for FFR 0.75), suggesting
that with this criterion approximately 60% of lesions with-
out functional significance would undergo PCI or surgery,
perhaps unnecessarily. Even though the MLA 4.8 mm2
excellently excluded FFR 0.80 in 89% of patients and
FR 0.75 in 96% of patients, normal FFR (0.80 and
0.75) was still observed in 18% and 36% of the lesions,
espectively, with a smaller MLA 4.8 mm2. Moreover, in
the presence of plaque rupture, the diagnostic accuracy was
only 77%. To avoid the wrong diagnosis in terms of
functional significance, invasive FFR or noninvasive stress
tests should precede the decision for treatment especially for
the lesions with MLA 4.8 mm2 or plaque rupture.
Recent studies have reported a worse correlation between
IVUS and FFR in intermediate non-LM disease than was
seen in LM lesions in the current study (17–19). Thus, the
diagnostic accuracy of the MLA cutpoint seems to be better
in LM lesions compared with the non-LM lesions. This
might be explained by the simplicity of morphological
characteristics of pure LM lesions, uniformly large vessel
Figure 2. Correlation Between MLA and FFR
The lesions with plaque rupture are represented as red circles. LM  left maisize, short lesion length, and lack of side branch and otheranatomical factors potentially affecting FFR. Additionally,
studied patients had no regional wall motion abnormalities
and mostly showed preserved left ventricular ejection frac-
tion. Consistent amount of viable myocardium might con-
tribute to minimize the influence on FFR.
The frequency of plaque rupture within the LM as a
culprit lesion and the impact of plaque rupture on functional
significance of stenosis have been unknown. The current
data identified plaque rupture in 38% of patients with stable
and unstable angina and suggested that plaque rupture
independently affected FFR. However, further study is
necessary to confirm the physiological effect of plaque
rupture.
Study limitations. First, the current study included a rela-
ively small number of patients with pure LM disease
ithout significant downstream disease. Second, we ex-
luded patients with significant LAD or left circumflex
rtery stenosis; this is a frequent problem in real practice.
ith the lack of validation with clinical outcomes, the
urrent study assumed FFR to be the gold standard and
nvestigated angiographic and IVUS morphological predic-
ors for currently accepted cutoff of FFR. Clinical follow-up
tudy with the new IVUS criteria should be performed in a
arge cohort to clarify the natural history of deferred lesions
ith the MLA 4.8 mm2 and to support guidelines for
evascularization strategy.
onclusions
In pure LM disease, an IVUS-derived MLA 4.8 mm2 is
nary artery; other abbreviations as in Figure 1.a useful criterion for predicting FFR 0.80.
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